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Chairman’s Foreword 
Clinical cardiac ekctrophysiology is the youngest of the 
cardiac subspecialities. The last decade has witnewzd im- 
pressive advances in both drug as well as nonpharmacologic 
methods for management of patients with cardiac arrhyth- 
miss and a number of centers have active tminine om~mm~ 
for arrhythmia specialists. The North American-&&y of 
Pacine. and Electroohvsioloev (NASPE) believed it desirable 
to a&date the b&diet% of a well rounded training 
program in clinical ekctrophysiology. It was appreciated 
that because clinical cardiac electrophysiology borrows 
heavily from a number of disciplines (i.e., cellular electro- 
physiology, clinical pharmacology, etc.). a committee of 
expeflswas formed to draft a statement defining the teaching 
objectives of a training program in clinical electmphyriol- 
WV. The draft statement was thorouehlv discussed at a 
p&y conference held during the g;h knnuol Scientific 
Sessions of NASPE in Mav 1987. Given the modem bodv of 
knowledge and variety of fomplex skills required to care for 
patients with cardiac arrhythmias, it was unanimously 
agreed that the minimal length of such a training program 
should he I year after completion of an approved training 
program in clinical cardiology. A 2 year program was ad- 
vi& forthosedesiring toacquire skills in theareaofcardiac 
electrasurgery. insertion of antitachycardia devices or cath- 
eter ablative procedures. lo our deliberations it WE clear 
that it would not be possible for every trainee to develop 
proficiency in all 3rea’l of clinical electrophysiology. It was 
felt to be important, however, that such programs allow for 
acquwtion of not only basic skills but critical judgment in 
the use of newer and complex treatment modalities. Clearly, 
heavy responsibility resides with program directors to en- 
sure that such a training program fulfills these goals. 
I. General Objectives 
The general ebiectives of a tninine om~mm in clinical 
cardaac &clroph&logy are to enabl; &&ees completing 
this program to: I) acquire knowledge of cellular and whole 
organ electraphysiology and principles of phammcology 10 
understand current theories of mechanisms of cardiac 
arrhythmias and effects of antiarhythmic dmgs: 2) become 
proficient in complex electmcardiogmphy and pmvide ex- 
pert consultative care for patients with cardiac arrhythmias: 
3) be able to perform independently and analyze properly the 
rcsult~ of both noninvasive and invasive electmphysiologic 
tests: 4) evaluate and direct the care of patients with cardiac 
arrhythmias. with knowledge of available pharmacologic and 
nonpharmacologic approaches; and 5) be familia with the 
indications and techniques for invasive electrophysiologic 
testing and the proper interpretation and integration of the 
rWdtS. 
11. Length of Training Program 
and Facilities 
It is recommended thet the trainee spend at least I year in 
a program rpeeificatty dedicated to clinical cardiac electm- 
ohvsiolom after a minimal traininx oeriod of 2 wars in 
&ral &invasive clinical cardiology: A 2 year pmgmm is 
recommended for those desiring skills related to cardiac 
electmsurgery, insertion of antitachycardia devices or cath- 
cter ablation. 
The program should be wliciently broad to provide 
c~posorc to a wide army of cardiac arrhythmia problems. 
The trainee should be actively involved in the care of 
inpatients and outpatients with complex cardiac arrhythmias 
and should have direct responsibi:i;y for the follow-up care 
of patients with pacemakers or other devices. The trainee 
should panicipate in the management of arrhythmias in 3. Effects of sympathetic and parasympathetic agonists 
pediatric and adult patients and be invulved in the direct care and antagonists and metabolic derangements 
of the patients. lie or she should perform a minimum of two 
primary (or initial) invasive ekctrophysiologic studies per 
D. Anriorrhyrhmic Dnrg Arrions 
week and assist in the insertion of cardiac pacemakers and 
I, Underlying mechanisms of action of antiarrhythmic 
antitacbycardia devices. 
drugs 
The minimal facilities of the elcctrophysiology training 
a. Membrane channels as receptors 
center include a catheterization laboratory as described in 
b. Drug-receptor interactions 
the American Heart Association Electrocardiography and 
c. Modulated and guarded receptor hypothesis 
Electrophyriology Subcommittee Report (11 and the North 
2. Cellular electmphysiologic effects of all classes of 
American Society of Pacing and Electmphysiology Policy 
antiarrhythmic drugs 
Conference “NASPE ad hoc Guidelines for Cardiac Ekc- 
3. Modulation of drug effects by metabolic alterations 
trophysiology Studies” (2). During the training period, it is 
(e.g.. pH and K+l or changes in the resting potential. 
desirable that the trainee be exposed to the techniaues of 
cardiac mapping, cardiac elecrr&urgery and catheter abla- 
tion. The training program should be closely affiliated with IV. Basic Pharmacokinetics and 
centers pe forming cardiac electrosurgery. Pharmacodynamics 
A. Basic Pharmncokiueric Principles 
III. Basic Electrophysiology 
A training program in clinical electrophysiology should 
provide an understanding of basic cellular mechanisms as 
related to clinical practice. These concepts include the 
determinants of normal cardiac rhythm. the genesis of 
arrhythmias and the antiarrhythmic action of drugs. 
A. Determiwrts of Normal Cnrdiar Rhyrhm 
I. Genesis of the resting potential in excilable cells 
2. Channels and ionic currents responsible for the action 
potential 
3. Differences between fast and slow response action 
potentials and their cellular cardiac location and re- 
sponse to overdrive suppression 
I. Absorptron of drugs from the gastrointestinal tract 
and from intramuscular sites 
a. Effects of lipid solubilitylionic charge on ahsorp 
Lion of drugs 
2. Distribution of drugs after administration 
a. Concepts of apparent volumes of distribution and 
absence of their relations to anatomic volumes 
h. E&IS of tissue and plasma protein binding on 
volumes of distribution 
3. Metabolism of drugs by hepatic and extrahepatic 
mechanisms 
a. Firs1 pass hepatic metabolism and its effects on 
oral medications 
h. Induction and inhibition of drug metabolism by 
diet, alchohol and other drugs (e.g.. cimetidine. 
barbiturates. phenytoin and rifatnpl’n) 
4. Elimination of drugs hv liver. kidney and lungs 
2. Electrotonus a.. Relation between klimination r.& const& and 
3. Fiber diameter half-life 
4. Passive membrane properties 
5. Resting membrane potential 
6. Maximal upstroke velocity 
7. Modulation of these factors by sympathetic and para- 
sympathetic agonists 
h. Difference between zero and first-order kinetics of 
elimination 
c. Clinical relevance of dowdependent (or concen- 
tration-dependent) kinetics (saturable processes) 
C. Germis qf Arrhyrhmim 
I. Abnormalities of impulse initiation 
a. Abnormal automaticity 
b. Triggered activity (early and delayed aflerdepola- 
rizutions) 
Lt. Clinicnl Phrrnnacolin~lics 
I. Dosing recommendations and therapeutic decisions 
based on the following concepts: 
a. Clearance as a determinant of steady state plasma 
concentration (renal. nonrenal and systemic) 
2. Characteristics of disordered impulse propagation 
a. Slow response 
b. Depressed fast response 
c. Reentry (excitable gap and leading circle models) 
d. Reflection 
h. Half-life lime to steady state 
c. Basic concepts of compartmental analysis 
d. Use and ab&e of loading doses 
e. Principles of therapeutic drug level monitoring 
f. Drug interactions 
e. Anisotropic condu;tion 
2. Prediction of the time to achieve a steady state based 
cm the expected half-life of a drug 
3. lnfomation necessary to consider the folloaing factor 
in selecting dosages: 
a. Influence of age and renal. hcpatic and cardnc 
disease on drug metabolism 
C. PhaMnocodytla~~rics-Bnric Conrcprs q”Dn~~ AC rbrtr 
I. Receptor theory 
2. Structure-activity relation of drug< 
3. Log dose-response relations 
4. Agonists 
5. Antagonists (competitive and noncompetitwe~ 
6. Therapeutic index 
2. Abnormalities in atnoventncularconduction and their 
localnation 
3. Fascicular blocks 
4. Presence and location of acces$“ry pathways 
5. Recognition of the site of origin or tachycardia mech- 
anisms. or both. for padew wrh supraventricular 
tachycardia 
6. Dtfferentiation of suprdvcnrricular tachycardia wnh 
aberrancy from ventricular precxcitalion 
B Yoirricalur Taclnwrhvlhmius 
D. Phormarodysor~ics and Phan,lurrllir,uri~.~ of ANti- 
arrhyrhmic Drugs 
1. Classes of antiarrhythmic drug action and the!r uiilily 
and limifations 
2. Differential effects of drugs on conduction and refrac- 
toriness of myocardial tissue, bypass tri?cts and His- 
Purkinje tissue 
3. Prevailing hypotheses on the actions of sodium chan- 
nel-blocking drugs and the clinical implications of 
these hypotheses for drug interactions 
4. The subsequent information for each of the cowen- 
tional and experimental antiarrhythmic agents 
a. Indications. contraindications. dosage. drug inter- 
actions, adverse effects, relative renal elimination 
of drug. relative degree of hepatic elimination. 
range of expected elimination half-life in normal 
subjects and in patients with renal, hepatic or heart 
failure 
Type\ 
a. Premature ventricular dep&riz&ions 
b. Nonsustained ventricular tachvcardia 
c. Susrained ventticular tachycirrdia 
d. Bidirectional ventricular tachyranlia 
e. Polymorphic ventricular tachycardia 
f. Repetitive monomorphic ventricular tachycardia 
Underlying etiology 
a. Previous myocadial infarc:ion patterns 
b. Hypertnphic myopathy 
c. Right ventricular dysplasia 
d. Long QT syndromes 
e. D&alis toxicity 
f. Coro!lary artery spasm 
g. Congeniml or repaired congenital heart defects 
h. Verapamil-sensitive ventricular tachycardia pat- 
E. Drug-Device Intemrriuns 
The trainee shouid be familiar with the eiTects of drugs on 
both pacing and defibrillation thresholds. 
V. Electr~ardiographylArrhythmia 
Ii is assumed that the trainee has already acquired the 
minimal competency requirements of cardiac fellows for 
electrocardiographic (ECG) interprelation as outlined in the 
American College of Cardiology Task Force reports (3.41. 
He or she is expected to be fully famdiar with the indications 
for and performance of the following noninvasive ECG tests: 
ambulatory KG recordings. continuous on-line KG moo- 
itoring (trattstelephonic ECG trdnsmissionl, analysis of sig- 
nal averaged ECGs for detection of late potentials and 
exercise stress testing, He or she should be able to evaluate 
and integrate the results of such testing for both diagnosis 
and treatment of patients with cardiac arrhythmias. 
A. Supruvenrricrdar Arrltylhmim 
1. Abnormal sinus node function 
tern 
1, Distinction between supnventriculdr and ventricular 
tachycardia 
o. Atrioventricular dissociation 
b. Fusion or capture beats 
c. QRS complex duration and morphology. 
VI. Invasive Electrophysiologic Studies 
1. Indications for invasive electrophysiologic testing 
2. Interpretation of the data derived from invasive clec- 
tmphysiologic testing 
3. Evaluation of the diagnostic and therapeutic implica- 
tions 
4. The sensitivity and specificit!: of electrophysiologr 
testing for each arrhythmia or clinical syndrome 
5. The anatomy and physiology of the normal cardiac 
conduction system and andlomic substrate for ventri- 
cular preexciration and ventricular tachycardia 
6. Rssources 
a. Support personnel for performance of invashe 
studies (including numbers and adequate training 
of nursing and technical support people) 
b. Programmable stimulators 
c. Recorders 
d. X-ray equipment 
c. Electrode cmbetcrs 
f. Appropriate electrical safety measures 
7. Equipment care and management 
a. Proper filter settings for all recordings, paper speed 
and gain standardization 
b. &polar recordings versus bipolar recordings 
c. Recognition of recording nnifacls 
8. Cutbscriration techniques 
a. Cannulatian of various peripheral venous and or- 
terial entry sites 
b. Catheter placement for recording from various 
intracardiac chambers (riaht atrium. His bundle 
regnon. right ventricle, coronary sinus. right ven- 
tricle, pulmonary awry, left ventricle) 
9. Risks 
a. Local hemorrhage 
b. Thrombosis 
c. Pericardial tamponade 
d. Arrhythmia induclion 
2. Pacing and recording techniques to assess sinus node 
function 
3. lntra- and interatrisl and atrioven:ricular conduction 
intervals during sinus rhythm and atrial pacing 
4. Cardiac refractory periods using the extrastimulus 
technique 
5. Ventriculoatrial conduction in terms of normal and 
abnormal retrograde atrial activalion sequence during 
ventricular pacing 
6. Concealed conduction resulting in delay and block 
conduction 
7. Identification and classification of the gap phenome- 
non and other related phenomena 
a. Atrioventricular node sod intrahisian or infrahisian 
block 
b. Unifascicular. bifascicular or trifascicular block 
P. Alternating bundle branch block 
d. Rate-dependent bundle branch block 
2. Significance of HV interval in patients with bifascicu- 
lar block or alternating bundle branch block 
3. Prognostic significance of atrial pacing-induced imra- 
hisian and infrahisian block. unifascicular, bifascicu- 
lar and trifascicular block during acute myocardial 
infarction and the potential for progression to ad- 
vanced or third degree atrioventricular block 
4. Effect of antiarrbythmic druzs on the cwdiac conduc- 
tion system 
5. Indications for permanent pacing in patients with 
chronic atrioventricular block according to site of 
block 
6. Type of pacing modality depending on physiologic 
needs 
D. Sqmwnwicrdor Tochycardia: Underlying Nec~rophy 
siologic Medonicms for Tuchycordia lnirirrtion 
I. Atrial overdrive pacing 
2. Atrial extrastimulus technique 
3. Ventricular pacing 
4. Ventricular extrastimulus technique for various typca 
of supravcntrk,ular tachycardia 
5. Distinction between the following: 
a. Type of supraventricular tachycardia based on 
clinical, eleclrocardiograpbic and electrophysiolo- 
gic criteria 
6. 
b. Type and location ofaccessory pathways from the 
I2 icad electrocardiogram and the various arrhytb. 
mias that occur and identify potential life- 
threatening arrby*%as. 
Site of origin or mechanisms of supraventricular 
tachycardia including the following: 
a. Atrial arrhythmias 
I) Sinus tachycardia 
2) Sinus node reentry 
3) Atrial automatic or reentrant achycardia 
4) Atrial flutter and fibrillation 
51 Sinus bradycardia. sinus pause/arrest and si- 
noatrial exit block 
b. Junctional arrhythmias 
I) Atrioventricular node (reenlrv) 
a) Common form 
b) Uncommon form 
2) Automatic 
a) Nonosroxvsm;~l iunctional tachvcardia 
b) J&tionaiauto&tic tachycard~a 
3) Atrioventricular tachycardia 
a) Onhodromic tachycardia 
bJ Antidromic tachycardia 
c) Nodoventricular Mahaim 
d) Permanent form of atrioventricular junc- 
tional reentry txhycardia 
7. Performance of the following 
a. lntracavitary pacing and mapping studies to locate 
the origin ofarrhythmia. the site of reentry and the 
accessory pathway(s) 
b. Interpretation of the electrophysiologic patterns 
produced during supraventricular tachycardia 
c. Indications for use of vagolync. vagomimeuc or 
aympathomimetic or rpecific antiarrhythmic drug\ 
in the course ofevalustmg pat;entr wth wpraven- 
tricular arrhythmias 
d. The effects of specific drug, on specific part, of the 
reentry circuit in patients wth xupraventricular 
tachycardia 
e. Assessment of drug effect usm: electrophy\,olo~s 
studies for diagnostic and thempeutlc purpose\ 
f. Discuss the uses and limilations of \erial etectro- 
pharmacologic studies for rupraventr~cular rachy- 
cardia control 
g. Describe indications for: 
I) Antiarrhythmic drugs 
2) Antitachycardia device 
3) Catheter ablation and surgery 
E. Venwicslur Td~.vvcnrdiu 
1. Differential diagnosis of wide complex tachycardia 
2. Criteria for diagnosis of ventricular lachycordia baxd 
on intracardiac studies 
3. Appropriate intracardiac catheters requred during 
ventricular tachycardia study 
4. Minimally acceptable programmed stimulation proto- 
col for ventricular tachycardia induction 151 
5. Recording and interpreting normal and abnormal elec- 
trograms 
6. Electrophysiologic characteristics of an automatic 
tachycardia. triggered rhythm and rcentrnnt wrhyth- 
mia (as applied to ventricular arrhythmias) 
7. Sensitivity and specificity of indxtion protocols de- 
pending on site of stimulation and number of stimuli 
used and the reproducibility of induction protocols 
8. Clinical significance of induced suslained or non- 
sustained monomorphic tachycardia. polymorphic 
tachycardia. ventricular fibrillation or noninducibility 
in terms of lhe presenting clinical problem 
9. Indications for serial electropharmacolozic tcsting 
IO. Stimulation protoals wed for txhycardia lermint 
Lion 
a. Rapid bunt pacing 
b. Rate adaptive pacing 
c. Scanning with one or more extrastimuli 
b. Recognition of deleterious hemodynsmic or isch- 
ermc consequences of suslained ventricular tachy- 
cerdia 
C. bmuoprmliw Mopping 
The tramee should be able to recognize the importance of 
1. Sensitivity and specificity of programmed ventricular 
stimulation for patients with aborted sudden death 
2. Variables that predict the clinical tour% of patients 
with aborted sudden death 
acquisition of multiple local ekctrognms from 
I. Atria1 and ventricular margins of the atrioventricular 
groove in patients with extranodal accessory path- 
ways during maximal ventricular preexcitntion. ven- 
tricula pacing and ~upmventricular tachycardia 
2. Both the epicardium and endocardium during electri- 
cally imtuced ventricular tachycardia to identify the 3. Antiarrhythmic drug responxs with programmed ven. 
tncular stm,“tat,on I” pattents wth sudden death 
4. Role of clcctrophysiologic studies in the evaluation of 
exit site of a ventricular tachycardia focus 
patients with sudden death due to drug-potentialed 
He or she should identify problems relating to interpretation 
ventricular tachycardiaiventricular fibrillation 
of mapping data with respect to 
5. Role of programmed ventricula stimulation I. Multiple ventricular tachycardio morphologies 
il. Pauents with congenital long QT syndrome 
h. Patients with acquired long QT syndrome 
c. Patients with ventricular tachycardia due to cow 
nary spasm or exercise-induced ventricular txhy- 
cardia. 
VII. Endocardial and Epicardial Mapping 
The tramee should acquire the knowledge necessary to 
ewtoatc clcctrophysiotogic mapping of patients with cardiac 
arrhythmias and integrate this knowledge into a therapeutic 
plan. 
A. Ge,,rrrr, ,rr,wp,r,o,iw, of Lwnl Elurrr,>~rtrrrr.~ 
I. Ddference between unipolar and bipolar signatr 
2. Eifect, of tiltering of the agnats 
3. Local activation times 
4. Lxe potentials 
5. Low amplitude palcntials 
6. Fraclionated electmgnms 
7. Continuous electrical activity 
R. C<,,,rtlrewr E,,dwml;ul M<,ppi,,~ T~clu,;< <II Slills 
I. Indic;ltions for mapping studies in palients with supra- 
ventricular and v&t&dar tachy&dia 
2. Elwrophysiologic concepts of entrainment. reset- 
ting. fusion activation. entry or exit block resulting 
from pacing interventions during sustained tachycar- 
dia 
3. Activation sequence for mapping by obtaming multi- 
ple electrogtams from different cndocardial sites dur- 
ing tachycardia and assigning activation times in reta- 
tmn to reference electmgnms 
4. Catheterization safety factors 
a. Avoidance of rupture of coronary sinus or cardiac 
chambers 
2. E~Tects of the ventriculotomy and geometric hanges on 
tachycardia morphology and rate. 
VIII. Cardiac Pacing and 
Antitachycardia Devices 
Trainees should participate in and be capable of managing 
patients with implanted devices for either bradycardias or 
mchycardias. 
1. Selection of patients 
2. Device implantation 
3. Postoperative patient care 
4. Longterm follow-up 
The minimal requirements of such a training program 
would not necessarily provide an experience sufficient to 
perform pacemaker implantation. Adequate training for per- 
forming pacemaker implantation has been published previ- 
ously (7). Specifically, trainees should know the following: 
I. Physiology ofelectrical stimulation and the genesis ofthe 
endwardial electragram 
2. Basic pulse generator design and function as it relates to 
this physiology 
3. Indications for the use of implanted devices for the 
management of bradyarrhythmias and lachyarrhythmias 
4. Differing capabilities of available pacing or defibrillation 
systems and their applications for specific underlying 
problems 
5 Potcnlial interactions between implanted devices and 
other therapies, such as antiarrhythmic drugs 
6. Those aspects ofelectrophysiologic testing needed during 
implantation of pacemakers or defibrillators including: 
a. Excitation threshold measurements 
b. Endacardial etectrogram characteristics 
c. Defibrillation threshold measurements 
7. Absolute and relative contraindicatioos to the use of each 
of the available devices 
8. Methods used for pacemaker and defibrillator follow-up: 
a. Differential diagnosis of each of the manifestations of 
device malfunction 
b. Use of external programmers and other noninvasive 
looIs for evaluation of these problems 
c. Indicators of battery depletion for various devices 
d. Methods for appropriate monitoring and detection of 
such indicators 
9. Potential complications of device therapy including those 
that occur during implantation and those seen during 
follow-up. 
IX. Surgical Treatment of Tachyarrhythmias 
I. Principles of open heart surgery in terms of techniques, 
risks and determinants of postoperative morbidity and 
mortality 
2. Indications for cardiac electmsurgery for arrhythmia con- 
trol 
3. Details of patient selection and preoperative valuation 
4. Current techniques, limitations and potential benefits of 
arrhythmia surgery 
5. lntraoperative techniques for locating the His bundle, 
accessory pathways and ventricular tachycardia foci 
He or she should: 
I. Participate in the operative and postoperative care of 
these patients 
2. Identify the need for adjunaive arrhythmia or surgical 
therapy 
a. Drugs 
b. Cardiac pacing 
c. Device insertion 
d. Ancillary sur&al procedures (e.g.. coronary bypass 
sumerY valve rcdacement) 
To x&e these adjectives. the training program should 
he closely affiliated with a medical center in which cardiac 
e!ectrosq&y is performed 
X. Catheter Ablation 
Although catheter ablative pmcedures are still experi- 
mental. the trainee should be familiar with indications and 
complications of this procedure but not necessarily able to 
perform them. The trainee should know the following: 
I. The possible causes of tissue damage induced by high 
energy electric shocks 
2. Impedance characteristics of these discharges 
3. Cause of bubble formation and flash response 
4. Peek voltage and current delivered using standard dbxct 
current defibrillator pulses in the 200 to 300 I stored 
energy range 
5. The type of histologic damage arrhythmias induced by 
high energy shocks 
A. A~riovenrrictdar Innehnwl Ablutioa 
I. Procedural details used for catheter ablation of the 
atrioventricular junction 
a. Catheter and patch placement 
b. Range of en&es to be used 
2. Types of arrhythmias amenable to catheter ablation of 
the atrioventricular junction. 
3. Indications for this procedure 
4. Short- and long-term complications 
5. Expected et?icacy in terms of producing complete 
atrioventricular block or rhythm cuntrol. or both 
6. Benefits and Precautionr of using this technique in 
Patients with the Wolff-Parkinson-White syndrome 
involving free wall versus septal accessory pathways 
2. Procedures used for cat~~eter ablation of postero- 
septal accessory pathways 
a. Efficacy 
b. Possible complications 
C. Ven~ricrdar Tachycwdiu A blurion 
I. Intricacies of catheter placement 
2. Wtails of measurement of endocardial potentials 
3. Role of overdrive or premature ventricular stimula- 
tion during ventricular txhycardia for location of the 
ventricular tachycardia exit site 
4. Relation between electrode catheter and external 
patch 
5. Energy ranges used for ventricular tachycardia bla- 
live procedures 
6. Indications. reported stlicacy and complications of 
this procedure. 
XI. References 
